🟢 West Pharmaceutical Services is trading 6.42% up in pre-market after beating estimates and raising full-year outlook

West Pharmaceutical Services is trading at $439.10, up 6.42%, as coverage links the move to October 29 results and raised guidance.

• Adjusted earnings were $2.66 per share and revenue was $874.5 million, both above analyst estimates.
• The company raised its full-year revenue and adjusted-EPS outlook; high-value product demand supported growth.
• Available coverage ties the positive reaction to the results but does not establish a separate November 2 announcement.